Dishman Pharmaceuticals and Chemicals has commissioned three API facilities for contract manufacturing. The $37.5m facilities are in Bavla, India. Dishman plans to commission a fourth facility dedicated to the production of cytotoxic compounds by the end the year.
India PR Wire
Thursday 8 May 2008
Dishman expands API capacity
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment